PMID: 6400038Jan 1, 1984Paper

Human monoclonal antibodies: methods of production and some aspects of their application in oncology

Medical Oncology and Tumor Pharmacotherapy
L Olsson

Abstract

The currently available methods for the production of human monoclonal antibodies (Mabs) are: mouse-human hybrids, human-human hybrids, EBV transformation, and fusion of EBV-transformed specific B-lymphocytes with a malignant cell line. Each method has its advantages and drawbacks, but they are all inferior to an optimal functioning mouse hybridoma system. A significant obstacle is the lack of a reproducible method to obtain high amounts of antigen-specific B-lymphocytes. However, it seems that newly developed in vitro antigen-priming methods may be a significant aid to the solution of this problem. Human Mabs have already been obtained against some types of human cancer, and the reactivity pattern has provided some biological information that seems not to be obtainable with non-human Mabs. It furthermore seems that the technology for production of human Mabs now has progressed to the stage where it permits a realistic hope that they soon can be applied in the diagnosis and treatment of human cancer.

References

May 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·R Levy, J Dilley
Jan 1, 1979·Annals of the New York Academy of Sciences·M K Hoffmann
Jul 1, 1976·European Journal of Immunology·G Köhler, C Milstein
Jul 1, 1975·Experimental Cell Research·J Schwaber
Nov 22, 1966·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·C Milstein
Nov 29, 1974·Nature·C MilsteinN J Proudfoot
Jul 1, 1972·Physiological Reviews·M Potter
Jul 6, 1973·Nature·R G Cotton, C Milstein
Aug 1, 1967·Proceedings of the Society for Experimental Biology and Medicine·Y MatsuokaD Pressman
Jan 2, 1982·Lancet·K SikoraJ V Watson
Sep 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·L Olsson, H S Kaplan
Mar 4, 1982·The New England Journal of Medicine·R A MillerR Levy
Jan 1, 1983·Advances in Cancer Research·A D Riggs, P A Jones
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·L Olsson, J Forchhammer
Nov 7, 1980·Science·A Razin, A D Riggs
Sep 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·R F IrieR E Saxton
Nov 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·D KozborJ C Roder
Mar 1, 1983·The Journal of General Virology·D H CrawfordP C Beverley
Jan 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·D Picard, W Schaffner
Jan 1, 1983·Annual Review of Biochemistry·W Doerfler
Oct 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·A OchiN Hozumi
Dec 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·N N TengH S Kaplan
Jan 1, 1983·British Journal of Cancer·K SikoraJ Watson
Jun 24, 1983·Journal of Immunological Methods·L OlssonB Jakobsen
Jan 1, 1983·Methods in Enzymology·L Olsson, H S Kaplan
Feb 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·V T OiP Berg
Feb 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·M K Hoffmann
Apr 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·R J CoteL J Old
Oct 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·J W LarrickJ C Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

© 2021 Meta ULC. All rights reserved